Popular Articles

New Brain Receptor, Possible Target For Alzheimer's Treatment, Identified By Barrow Researchers
Barrow Neurological Institute researchers have identified a novel receptor in the brain that is extremely sensitive to beta-amyloid peptide (AB) and may play a key role in early stages of Alzheimer"s disease.

Gene Network Sciences Announces Broad Cancer Collaboration With UCSF And Initial Results
Gene Network Sciences, Inc. (GNS) announced that it has entered into a research collaboration with the University of California San Francisco Cancer Center (UCSF) aimed at accelerating cancer research and drug development across several therapeutic areas. This collaboration will combine the clinical and research oncology expertise of UCSF with the computational expertise and supercomputer-driven REFS(TM) platform of GNS. Financial terms of the agreement were not disclosed.
News of the day
Health Insurance

Pitt School Of Medicine's George K. Michalopoulos, M.D., Ph.D., Receives 2009 ASIP Rous-Whipple Award

George K. Michalopoulos, M.D., Ph.D., Maud L. Menten Professor and chair of pathology, University of Pittsburgh School of Medicine, has received the 2009 American Society for Investigative Pathology (ASIP) Rous-Whipple Award. The award is presented annually to a senior scientist with a distinguished career in research who continues to advance the understanding of disease. Dr. Michalopoulos was honored for his research regarding the pathways of growth factors that lead the liver to regenerate. As the recipient, Dr. Michalopoulos presented a lecture on liver regeneration at ASIP"s annual meeting in New Orleans in April. His lecture will form the basis of a publication in The American Journal of Pathology. "This is a once in a lifetime achievement and I am touched to receive this recognition from my peers," said Dr. Michalopoulos. A native of Athens, Greece, Dr. Michalopoulos received his medical degree from Athens University Medical School and his doctorate in oncology from the University of Wisconsin. As one of the nation"s leading academic centers for biomedical research, the University of Pittsburgh School of Medicine integrates advanced technology with basic science across a broad range of disciplines in a continuous quest to harness the power of new knowledge and improve the human condition. Driven mainly by the School of Medicine and its affiliates, Pitt has ranked among the top 10 recipients of funding from the National Institutes of Health since 1997 and now ranks fifth in the nation, according to preliminary data for fiscal year 2008. Likewise, the School of Medicine is equally committed to advancing the quality and strength of its medical and graduate education programs, for which it is recognized as an innovative leader, and to training highly skilled, compassionate clinicians and creative scientists well-equipped to engage in world-class research. The School of Medicine is the academic partner of UPMC, which has collaborated with the University to raise the standard of medical excellence in Pittsburgh and to position health care as a driving force behind the region"s economy. For more information about the School of Medicine, see http://www.medschool.pitt.edu. University of Pittsburgh


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):